Featured News
AIM Blog
A Smart Investment in Our Future: New Funding Fuels Progress Against Dementia
AIM is celebrating another win for families impacted by dementia. The fiscal year (FY) 2026 spending package was recently signed into law, securing a $100 million increase for Alzheimer’s and dementia...
All News
AIM Blog
Taking Action During Alzheimer’s & Brain Awareness Month
More than 6 million Americans are living with Alzheimer’s. Throughout Alzheimer’s & Brain Awareness Month, federal and state policymakers and...
Press Release
Senate HELP Committee Advances Bipartisan Legislation to Renew Nation’s Commitment to Addressing the Alzheimer’s Crisis
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., June 15, 2023 — Today the Senate Committee on...
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...